KalVista Pharmaceuticals, Inc. (KALV)
NASDAQ: KALV · IEX Real-Time Price · USD
10.35
-0.86 (-7.67%)
At close: Apr 24, 2024, 4:00 PM
10.25
-0.10 (-0.97%)
After-hours: Apr 24, 2024, 7:13 PM EDT
KalVista Pharmaceuticals Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for KALV stock have an average target of 26.33, with a low estimate of 20 and a high estimate of 35. The average target predicts an increase of 154.40% from the current stock price of 10.35.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for KALV stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 2 | 2 | 2 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $35 | Strong Buy | Reiterates | $35 | +238.16% | Apr 11, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $24 | Strong Buy | Reiterates | $24 | +131.88% | Mar 12, 2024 |
| Needham | Needham | Strong Buy Maintains $35 | Strong Buy | Maintains | $35 | +238.16% | Mar 11, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $16 → $24 | Strong Buy | Maintains | $16 → $24 | +131.88% | Feb 14, 2024 |
| Needham | Needham | Strong Buy Maintains $22 → $35 | Strong Buy | Maintains | $22 → $35 | +238.16% | Feb 13, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
21.03M
EPS This Year
-3.09
from -3.33
EPS Next Year
-2.49
from -3.09
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | n/a | 37.3M | 225.7M | 233.5M | 302.8M | 374.9M |
| Avg | n/a | 21.0M | 119.6M | 146.7M | 214.0M | 290.0M |
| Low | n/a | 12.5M | 50.7M | 68.8M | 100.8M | 152.4M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | 973.6% | 95.1% | 106.5% | 75.1% |
| Avg | - | - | 469.0% | 22.6% | 45.9% | 35.5% |
| Low | - | - | 141.0% | -42.5% | -31.2% | -28.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -2.98 | -1.80 | 1.09 | 1.33 | 2.40 | 3.82 |
| Avg | -3.09 | -2.49 | -0.52 | -0.33 | 0.91 | 2.31 |
| Low | -3.10 | -3.05 | -1.64 | -2.01 | -1.31 | -0.19 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | - | - | 317.9% |
| Avg | - | - | - | - | - | 152.8% |
| Low | - | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.